Stephen Guilfoyle in his Market Recon column bemoans arrogant Fed heads, checks out Advanced Micro Devices' (AMD) disappointing pre-announcement and Eli Lilly's (LLY) good Tirzepatide news, wonders whether the market has been enough carnage for now, and waits for September jobs data....XLE